Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiology
- 1 July 1988
- journal article
- case report
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 78 (1), 1-7
- https://doi.org/10.1111/j.1600-0447.1988.tb06293.x
Abstract
The author reviews the literature reporting the untoward effects of withdrawing monoamine oxidase inhibitors (MAOIs). The withdrawal of these agents can result in severe anxiety, agitation, pressured speech, sleeplessness or drowsiness, hallucinations, delirium and paranoid psychosis. MAOI withdrawal phenomena resemble the symptoms produced by the discontinuation of chronically administered psychostimulants. The capacity of MAOI to exert amphetamine-like effects presynaptically, and the propensity of somatic treatments for depression to subsensitize presynaptic receptors regulating the release of catecholamines, can provide a basis for the development of psychotic syndromes upon the withdrawal of MAOIs. Evidence for this hypothesis is reviewed.Keywords
This publication has 36 references indexed in Scilit:
- The Effects of Midazolam and Temazepam on Sleep and Performance When Administered in the Middle of the NightJournal of Clinical Psychopharmacology, 1985
- Possible subsensitization of alpha2-adrenergic receptors by chronic monoamine oxidase inhibitor treatment in psychiatric patientsPsychiatry Research, 1982
- Changes in α- and β-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressantsNeuropharmacology, 1982
- α 2 -Adrenoceptor-Mediated Hyperpolarization of Locus Coeruleus Neurons: Intracellular Studies in VivoScience, 1982
- Presynaptic ReceptorsAnnual Review of Pharmacology and Toxicology, 1981
- Electroconvulsive Shock: Progressive Dopamine Autoreceptor Subsensitivity Independent of Repeated TreatmentScience, 1980
- Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatmentNature, 1980
- Long-term changes in the sensitivity of pre- and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studiesBrain Research, 1977
- Self-inhibition by dopaminergic neurones: Disruption by (±)-α-methyl-p-tyrosine pretreatment or anterior diencephalic lesionsNeuropharmacology, 1976
- The Clinical State, Sleep and Amine Metabolism of a Tranylcypromine (‘Parnate’) AddictThe British Journal of Psychiatry, 1965